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Abstract
Background: Preterm birth is a significant public health concern and exposure to phthalates has been shown to
be associated with an increased odds of preterm birth. Even modest reductions in gestational age at delivery could
entail morbid consequences for the neonate and analyzing data with this additional information may be useful. In
the present analysis, we consider gestational age at delivery as our outcome of interest and examine associations
with multiple phthalates.
Methods: Women were recruited early in pregnancy as part of a prospective, longitudinal birth cohort at the
Brigham and Women’s Hospital in Boston, Massachusetts. Urine samples were collected at up to four time points
during gestation for urinary phthalate metabolite measurement, and birth outcomes were recorded at delivery.
From this population, we selected all 130 cases of preterm birth (< 37 weeks of gestation) as well as 352 random
controls. We conducted analysis with both geometric average of the exposure concentrations across the first three
visits as well as using repeated measures of the exposure. Two different time to event models were used to
examine associations between nine urinary phthalate metabolite concentrations and time to delivery. Two different
approaches to constructing a summative phthalate risk score were also considered.
Results: The single-pollutant analysis using a Cox proportional hazards model showed the strongest association
with a hazard ratio (HR) of 1.21 (95% confidence interval (CI): 1.09, 1.33) per interquartile range (IQR) change in
average log-transformed mono-2-ethyl-5-carboxypentyl phthalate (MECPP) concentration. Using the accelerated
failure time model, we observed a 1.19% (95% CI: 0.26, 2.11%) decrease in gestational age in association with an
IQR change in average log-transformed MECPP. We next examined associations with an environmental risk score
(ERS). The fourth quartile of ERS was significantly associated with a HR of 1.44 (95% CI: 1.19, 1.75) and a reduction of
2.55% (95% CI: 0.76, 4.30%) in time to delivery (in days) compared to the first quartile.
Conclusions: On average, pregnant women with higher urinary metabolite concentrations of individual phthalates have
shorter time to delivery. The strength of the observed associations are amplified with the risk scores when compared to
individual pollutants.
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Background
Phthalate diesters are produced in large quantities yearly
in the US for use in everyday products such as polyvinyl
flooring, shower curtains, food packaging plastics, and
personal care products. Exposure occurs through contact
with these products as well as the consumption of con-
taminated food and drinking water [1–3]. Phthalate ex-
posure has been related to various health outcomes in
humans, including altered thyroid and reproductive hor-
mone levels [4, 5], decreased semen quality in males [6],
and asthma and allergic symptoms [7]. Exposure to
phthalates in utero has been linked to adverse birth out-
comes as well, including altered reproductive tract devel-
opment in male infants [8], neurodevelopment in both
sexes [9, 10], and both prematurity and small size at
birth [11–14]. Preterm birth, defined as delivery before
37 weeks completed gestation, is a particularly important
endpoint of interest due to: 1) its contribution to neo-
natal mortality and morbidity and consequent cost to so-
ciety; 2) the apparent increase in rates over the last three
decades; and 3) poorly understood causes and lack of ef-
fective interventions [15]. Not only is preterm birth the
leading cause of perinatal and infant mortality, but it is
also associated with adverse developmental outcomes in
children, including chronic conditions such as cardiovas-
cular disease and endocrine disorders [15–17]. The soci-
etal costs of preterm birth comprise high medical
expenditures and utilization and consequently places
economic burdens on healthcare systems [15]. Research
to uncover contributing causes, particularly those in
connection with environmental contaminant exposures,
is a public health priority [18].
We recently demonstrated clear associations be-
tween maternal urinary phthalate metabolite concen-
trations averaged from multiple time points during
pregnancy and increased odds of preterm birth in a
nested case-control study (N = 130 cases, N = 352 con-
trols) of women who delivered at the Brigham and
Women’s Hospital in Boston [14]. In follow-up ana-
lyses we examined variability in phthalate levels
across pregnancy, attempted to identify any patterns
in levels by gestational age, and assessed associations
between phthalate exposure biomarkers at individual
time points during pregnancy and preterm birth in
order to identify windows of vulnerability [19]. Upon
human exposure, phthalates are metabolized quickly,
therefore single spot urine samples are less predictive
of long-term exposure, and measurement of multiple
urine samples are more reliable [20]. While these re-
sults suggested that the third trimester of pregnancy may
be particularly sensitive for the relationship between
phthalate exposure and early delivery, the strongest ob-
served effect estimates were with the more stable metric
of average phthalate exposure over gestation.
Studying preterm birth as a binary outcome is reason-
able because variation in gestational age at delivery
around 40 weeks can be due to misclassification. Thus,
examining a cutoff such as 37 weeks focuses on preg-
nancies that are most likely to be truly early, and that
are clinically significant. However, some studies indicate
that “preterm birth” is not a homogeneous condition;
early delivery—regardless of gestational age—is associ-
ated with poorer health outcomes in childhood. For ex-
ample, late preterm birth (delivery at 34–36 weeks
gestation) is associated with increased likelihood of cere-
bral palsy and other developmental disorders such as re-
duced mental index scores compared to births that
occur at term (after 37 weeks gestation) [21, 22]. Thus,
examining the relationship between environmental expo-
sures and the rest of the gestational age distribution
could be biologically meaningful.
In this present analysis, we consider time to delivery
as our primary outcome of interest instead of the binary
outcome of term vs. preterm birth. We consider both
average exposure during pregnancy as well as repeated
measures of exposure across pregnancy as potential cor-
relates of time to delivery in this framework. In addition
to analyzing each compound separately, we constructed
two aggregate summaries of total phthalate exposure, an
environmental risk score [22] and a weighted quantile
sum [23], in relation to time to delivery. These aggregate
summary analyses attempt to capture the effect of mix-
tures on time to delivery.
Methods
Study population
Participants were part of an ongoing prospective cohort
study of pregnant women with initial prenatal visits at
clinics in the Boston area. All women who wished to
participate were included if they planned to deliver at
the Brigham and Women’s Hospital and if their initial
visit was prior to 17 weeks gestation. Subjects were
followed throughout the course of pregnancy and pro-
vided information (e.g., health status, weight) and urine
samples at up to four visits. Urine samples were refriger-
ated (4 C) for a maximum of two hours before being
processed and frozen (− 80 C) for long-term storage. At
delivery, birth outcome characteristics such as mode of
delivery and fetal measurements were recorded. From
2006 to 2008 approximately 1600 women were recruited,
and 1181 were followed until delivery and had live
singleton infants. From this population, the present
nested case-control study includes all 130 mothers who
delivered preterm, as well as 352 controls selected ran-
domly from subjects who had a urine sample from visit
1 and from at least one additional visit.
Gestational ages at individual visits and at delivery
were calculated based on last menstrual period (LMP)
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and confirmed by first trimester ultrasound. Study par-
ticipants provided written informed consent and institu-
tional review board approval was obtained from
Brigham and Women’s Hospital and the University of
Michigan. Within this study, visit 1 urine samples were
taken at median 9.71 weeks gestation (range 4.71 to
16.1 weeks), visit 2 at median 17.9 weeks (range 14.9 to
21.9 weeks), visit 3 at median 26.0 weeks (range 22.9 to
29.3 weeks), and visit 4 at median 35.1 weeks (range
33.1 to 38.3 weeks). The number of subjects with sam-
ples available decreased slightly with increasing visit,
with the fourth visit having the smallest number of
samples. Visit 4 also had a smaller proportion of
cases with urine samples, since some had delivered by
this time point.
Phthalate exposure
Nine phthalate metabolites were measured in each avail-
able urine sample (N = 1693) by NSF International in
Ann Arbor, MI, following methods developed by the
Centers for Disease Control (CDC), described in detail
elsewhere [24, 25]. The final number of samples ana-
lyzed for all phthalate metabolites were as follows by
visit (cases, controls): Visit 1 (129, 350); Visit 2 (118,
304); Visit 3 (111, 301); and Visit 4 (66, 314). Phthalate
measurements below the limit of detection (LOD) were





To adjust for urinary dilution, specific gravity (SG)
levels were also measured in each urine sample using a
digital handheld refractometer (ATAGO Company Ltd.,
Tokyo, Japan). For univariate analyses phthalate levels
were corrected for urinary SG using the following for-
mula: PC = P[(MSG − 1)/(SG − 1)], where PC represents
the SG-corrected phthalate concentration (micrograms
per liter), P represents the measured concentration in
urine, MSG = 1.015 is the median SG of all samples
measured, and SG represents the SG of the individual
sample [12].
For regression models, unadjusted phthalate levels
were used and urinary SG was included as a covariate,
since modeling adjusted phthalate levels may incur bias
[27]. In the analysis of individual phthalate metabolites,
we additionally examined a summed measure of
di(2-ethylhexyl) phthalate (DEHP) metabolites (ΣDEHP;
nanomoles/liter) that is typically calculated as an index
of total exposure to the parent compound. All individual
metabolites and ΣDEHP were log-normally distributed
and ln-transformed for analysis.
Descriptive analysis
The nested case-control sample was appropriately
weighted via inverse probability weighting in order to
compute representative descriptive statistics and to make
inference on time to birth for the overall cohort. All ana-
lyses utilized these weights. Population-level summary
statistics were computed for demographic characteris-
tics, including race, maternal age, education, and health
insurance provider (public vs. private). Race, maternal
age, and education were included as covariates in all
single-pollutant and multi-pollutant analysis models.
The distribution of each log-transformed phthalate
metabolite and final gestational age were assessed via
histogram. To evaluate the concordance between differ-
ent phthalates, a Pearson correlation matrix between
log-transformed and specific gravity corrected average
phthalate metabolite concentrations was tabulated.
Analysis with average exposure
Single-pollutant models
One common strategy to model repeated exposure
measurements is to compute the average contaminant
concentration for each individual and subsequently
use the average exposure concentration in the model
of interest. In this context, average exposure for a
particular phthalate metabolite refers to the average
of the log-transformed concentrations obtained at the
first three visits. We excluded the fourth visit from
our average exposure analysis because women with
preterm deliveries were less likely to have a fourth
visit. We will consider three such mean exposure ana-
lysis models: (1) Logistic Regression, (2) Cox Propor-
tional Hazards Model, and (3) Accelerated Failure
Time Model. All coefficients are reported in the unit
of one interquartile range (IQR) change of the expos-
ure under consideration. Standardizing by IQR allows
us to compare two subjects with identical covariates,
one of which is at the 75th percentile of exposure
and the other is at the 25th percentile of exposure.
Logistic Regression with Preterm Birth as Outcome: Let
Ti denote the gestational age at delivery for subject i (in
days) and let Ei ¼ IðTi < 37 wksÞ indicate whether sub-
ject i had a preterm birth, where i = 1, ⋯, 479. Then the
single-pollutant logistic regression model for the k th
phthalate can be expressed as:
logit πikð Þ ¼ β0k þ β1kXik þ ZTi β2k ; ð1Þ
where πik ¼ PðEi ¼ 1jXik ;ZiÞ, Xik is the mean of the k th
phthalate (log-transformed) divided by the IQR of the log-
transformed k th phthalate for the i th individual, k = 1⋯,
9, and ZTi is a vector of baseline covariates for the i th in-
dividual (race, education, maternal age, average specific
gravity across the first three visits, and health insurance
status). The fitted coefficients expðβ^1kÞ provide an esti-
mated odds ratio of preterm birth for one IQR increase in
average log-transformed phthalate levels. Similar results
were presented in Ferguson and colleagues (2014), but are
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included to compare with the repeated measures single-
pollutant exposure results [14].
While logistic regression is easy to implement and in-
terpret, it has the drawback of discretizing gestational
age at delivery. Thus, we consider gestational age at de-
livery as a continuous outcome and fit two commonly
used time to event models. The distinction from a stand-
ard survival context is that everyone in the study experi-
ences the event and the distribution of time to delivery
is left skewed (instead of a survival time distribution,
that is typically right skewed).
Cox Proportional Hazards Model: The first obvious
and natural way to correlate the outcome of gestational
age at delivery to phthalate levels is to model the hazard
of having birth at time t, λk(t), as a function of the covar-
iates and the k-th phthalate metabolite,
λk tð Þ ¼ λ0k tð Þ exp α1kXik þ ZTi α2k
 
; ð2Þ
for k = 1, ⋯, 9, where Xik and ZTi are defined above. The
fitted coefficients expðα^1kÞ provide an estimated hazard
ratio of giving birth at time t for a one IQR change in
average phthalate exposure (log-transformed). Numbers
larger than one indicate an increased hazard ratio of de-
livery and, therefore, a shorter time to delivery.
Accelerated Failure Time Model: Although Cox pro-
portional hazards model is the most commonly used
model for time to event data, our direct objective of asso-
ciating gestational age at delivery (rather than modeling
the instantaneous hazard at time t) to phthalate levels is
better addressed by the accelerated failure time model
which, in this case, simply reduces to modeling the log of
gestational age as a normal linear regression model:
logðTiÞ ¼ γ0k þ γ1kXk þ ZTi γ2k þ σϵi; ð3Þ
where Xik and ZTi are defined above and the errors ϵi
are independent standard normal variates. Both models
provide natural interpretations of their respective par-
ameter estimates. For the accelerated failure time model,
100 ð expðγ^1kÞ−1Þ, yields the percent change in gesta-
tional age at delivery per IQR increase in the kth log-
transformed phthalate exposure. Negative numbers indi-
cate shorter time to delivery.
Multi-pollutant models
While the standard practice has been to consider
single-pollutant models, in reality, we are exposed to
mixtures of multiple agents. A direct approach to mod-
eling multiple pollutants is to construct a joint multivari-
ate model with all 9 phthalate metabolites. This
approach is often not feasible due to lack of sample size
and potential multicollinearity among exposures. Two
recently proposed strategies consider weighted sum type
metrics that represent the composite effect of mixtures.
The first such method is to construct an environmental
risk score (ERS) [22]. ERS is calculated as a linear com-
bination of the individual contaminant exposures,
weighted by their associated regression coefficients
obtained from a given model. Another method of quan-
tifying aggregate exposure to multiple environmental
contaminants is through a weighted quantile sum
(WQS), where adaptive weights corresponding to chosen
quantiles of phthalates are estimated by bootstrapping
the data [23]. In both summative risk scores, the weights
are derived from a model of the association between
chemical mixtures and the health outcome of interest.
To avoid multicollinearity issues incurred by the inclu-
sion of all 9 phthalates, we adopted two approaches to se-
lect subsets of phthalates for ERS and WQS construction.
The first approach examined the correlation structure of
the phthalates (Additional file 1: Table S1). Five phthalates
in the upper-left block show strong correlation (greater
than 0.5) and, among them, we chose the one that showed
the strongest association with gestational age at delivery
(MECPP). The ERS and WQS determined by this empirical
examination of correlations were subsequently based on six
phthalate metabolites: MECPP, MBzP, MBP, MiBP, MEP,
and MCPP. We call the two risk scores based on such ad
hoc screening of the correlation structure “ERS-Corr” and
“WQS-Corr.” The second approach constituted of running
stepwise logistic regression with all 9 candidate phthalates
and selecting the phthalates that were retained at the end
of the stepwise procedure. The risk scores based on the
phthalates selected by stepwise variable selection are called
“ERS-Stepwise” and “WQS-Stepwise.” Details regarding
data adaptive weight construction for these risk scores are
relegated to Additional file 1: Appendix A1.
Analogous to single-pollutant models (1), (2), and (3),
similar models with the continuous summative risk
scores (or categorized values of the risk scores), generic-
ally denoted as RS in the following expressions, were fit.
All risk scores were standardized by their respective IQR
in order to facilitate comparisons between risk scores.
Logistic Regression: logitðπRSi Þ ¼ βRS0 þ βRS1 RSi þ ZTi βRS2 ,
where πRSi ¼ PðEi ¼ 1jRSi;ZiÞ.
Cox proportional hazards model: λRSðtÞ ¼ λRS0 ðtÞ
expðαRS1 RSi þ ZTi αRS2 Þ.
Accelerated failure time model: logðTiÞ ¼ γRS0 þ γRS1 R
Si þ ZTi γRS2 þ σϵi.
Analysis with repeated measures of exposure
Single-pollutant models
In a traditional repeated measures situation, repeated mea-
sures are taken on the outcome of interest, potentially ad-
justed for time independent covariates. However, in our
scenario, we have up to four repeated measures per expos-
ure in each subject. To capture the variation in phthalate
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levels across pregnancy, we consider a two-step method as
described in Chen and colleagues (2015) [28]. The two-step
method consists of: (a) fitting a linear mixed effects model
with random intercepts to the repeated measures of the
phthalate levels (b) extracting the estimated subject-specific
intercepts to be used as a predictor in the second-step out-
come model, akin to the mean analysis presented through
models (1), (2), and (3).
Note that the differences between average exposure across
visits and subject-specific intercepts are small. However,
using subject-specific intercepts is a more general approach
as random slopes or other features may be incorporated into
the stage 1 linear mixed model (LMM). Moreover, the
LMM framework better addresses subjects with differing
numbers of visits, because BLUPs are shrinkage estimates of
subject-specific averages relative to the population average.
In that respect, we feel that the LMM framework is a statis-
tically principled analog to the more ad hoc approach of tak-
ing a simple exposure average. The details of this fitting
process are provided in Additional file 1: Appendix A2.
Multi-pollutant models
For the repeated measures analysis, we will only focus
on ERS-Corr and ERS-Stepwise (we cannot use WQS,
because the outcome in the linear mixed effects model
needs to be continuous and WQS is inherently discrete
by construction). We repeat the process of constructing
the ERS at each time point (Visits 1–4) and fit a random
intercept linear mixed model to the repeated measures
of ERS at each time point. That is, we first fit:
ERSij ¼ b0i þ ϕ0 þ ϕ1Tij þ ϕ2SGij þ ϵij;
where SGij is the specific gravity for the ith subject at
the jth visit and b0i∼Nð0; σ2bÞ and ϵi j∼Nð0; σ2Þ are inde-
pendent. Let b^0i be the best linear unbiased predictors
(BLUP) of the subject-specific random intercepts,
extracted from a standard linear mixed effects model
output, and let b^

0i denote the IQR standardized BLUP.
Then our final analysis models are of the form:
Logistic regression model:
logitðπRSi Þ ¼ βRS0 þ βRS1 b^

0i þ ZTi βRS2 , where πRSi ¼ PðEi
¼ 1jb^0i;ZiÞ.
Cox proportional hazards model:
λRS tð Þ ¼ λRS0 tð Þ exp αRS1 b^

0i þ ZTi αRS2
 
:
Accelerated failure time model:
log Tið Þ ¼ γRS0 þ γRS1 b^

0i þ ZTi γRS2 þ σϵi:
All analyses were performed using R statistical soft-
ware, version 3.4.4 (www.r-project.org). WQS was imple-
mented using the gWQS package in R [29].
Results
Summary statistics for the study population with respect
to demographic characteristics such as race, education,
maternal age, and health insurance status can be found
in Additional file 1: Table S2. Overall, the cohort primar-
ily had private health insurance and was highly educated,
with 79.9% of the study participants having privatized
health insurance and 83.6% of women completing some
postsecondary education at a college or technical school.
There were minimal differences between cases and con-
trols with respect to race, education, maternal age, and
health insurance status. Descriptive summary character-
istics for the distribution of phthalate metabolite con-
centrations are provided in supplementary Table S3. All
contaminant distributions are right-skewed and each
phthalate metabolite has a very low percentage of
non-detects, with the largest being 4.70% of values
below LOD for MEHP. Additional file 1: Figure S1
shows that the distribution of gestational length is heav-
ily left-skewed.
Table 1 summarizes the odds ratios, hazard ratios, and
percent change in the single-pollutant mean exposure
analysis models (see Additional file 1: Table S4 for
single-pollutant IQR values used in interpreting model
coefficients). MEHP (OR: 1.50, 95% CI: 1.10, 2.07),
MECPP (OR: 1.66, 95% CI: 1.20, 2.30), and summed
DEHP metabolites (OR: 1.47, 95% CI: 1.06, 2.03) all
showed elevated odds of preterm birth per IQR change
in their respective mean log-transformed concentrations
adjusted for average specific gravity, race, education,
maternal age, and health insurance status. Considering
gestational age as a continuous outcome, the Cox pro-
portional hazards model identifies MECPP (HR: 1.21,
95% CI: 1.09, 1.33), summed DEHP metabolites (HR:
1.14, 95% CI: 1.04, 1.26), MBzP (HR: 1.15, 95% CI: 1.03,
1.27), MBP (HR: 1.17, 95% CI: 1.05, 1.29), and MCPP
(HR: 1.10, 95% CI: 1.01, 1.20), as having a significant HR
of delivery per IQR change in their respective mean
log-transformed concentrations. The single-pollutant ac-
celerated failure time models identify MECPP as having
a 1.19% (95% CI: 0.26, 2.11%) decrease in final gesta-
tional age in days and summed DEHP as having a 1.03%
(95% CI, 0.01, 1.95%) decrease in final gestational age in
days for one IQR higher in average log-transformed
MECPP and summed DEHP, respectively.
Table 2 summarizes the odds ratios, hazard ratios, and
percent change in the single-pollutant repeated mea-
sures analysis models using random intercepts (see
Additional file 1: Table S4 for BLUP IQR values used in
interpreting model coefficients). First-step models
adjusted for time-varying specific gravity and all
second-step models adjusted for race, education, mater-
nal age, and health insurance status. MEHP (OR: 1.40,
95% CI: 1.06, 1.85), MECPP (OR: 1.43, 95% CI: 1.12,
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1.83), and summed DEHP metabolites (OR: 1.32, 95%
CI: 1.01, 1.74) showed higher odds of a preterm birth
per IQR change in the subject-specific random intercept.
MECPP (HR: 1.11, 95% CI: 1.03, 1.19), MBzP (HR: 1.13,
95% CI: 1.05, 1.22), MBP (HR: 1.11, 95% CI: 1.04, 1.19),
and MCPP (HR: 1.06, 95% CI: 1.00, 1.12) showed an ele-
vated risk of shortened gestational length per IQR
change in their respective mean log-transformed con-
centrations. Moreover, summed DEHP metabolites had a
nearly significant hazard ratio after accounting for the
repeated measures of DEHP metabolites (HR: 1.07, 95%
CI: 0.99, 1.16). In the accelerated failure time model,
MECPP (% Change: -0.74, 95% CI: -1.14, − 0.03%) was
the only metabolite that was significantly associated with
a percent decrease in final gestational age per IQR
change in the subject-specific MECPP random intercept.
Overall, results for the repeated measures analysis are
consistent with the mean exposure analysis. One notable
difference is that the results in Table 2 are generally at-
tenuated relative to the results in Table 1. Intuitively,
this is because extracting summaries of phthalates by
random effects and associating them with gestational
length are “noisier” than directly using averaged
measurements.




OR 95% CI HR 95% CI % Change 95% CI
MEHP 1.40 (1.06, 1.85) 1.03 (0.96, 1.12) −0.52% (−1.28, 0.26%)
MEHHP 0.97 (0.74, 1.26) 0.98 (0.91, 1.07) −0.14% (−0.90, 0.63%)
MEOHP 1.10 (0.85, 1.42) 1.02 (0.95, 1.10) −0.33% (−1.07, 0.40%)
MECPP 1.43 (1.12, 1.83) 1.11 (1.03, 1.19) −0.74% (−1.14, − 0.03%)
Σ DEHP 1.32 (1.01, 1.74) 1.07 (0.99, 1.16) −0.64% (−1.14, 0.13%)
MBzP 1.08 (0.81, 1.42) 1.13 (1.05, 1.22) −0.50% (−1.28, 0.28%)
MBP 1.18 (0.97, 1.46) 1.11 (1.04, 1.19) −0.44% (−1.11, 0.24%)
MiBP 0.93 (0.72, 1.19) 0.98 (0.92, 1.05) 0.33% (−0.38, 1.04%)
MEP 1.10 (0.82, 1.46) 0.98 (0.90, 1.06) 0.04% (−0.78, 0.87%)
MCPP 1.19 (0.95, 1.48) 1.06 (1.00, 1.12) −0.19% (−0.84, 0.46%)
Phthalate measurements at each visit were log-transformed. All models were adjusted for specific gravity at the respective visit, time of sample collection,
maternal age at first visit, race, and education. The single-pollutant models for MBzP, MBP, MiBP, MEP, and MCPP are also adjusted for health insurance provider.
Bolded cells indicate significant (p < 0.05) odds ratios (OR), hazard ratios (HR), and percent changes (% Change). Odds ratios, hazard ratios and percent changes
are all calculated on IQR (Interquartile Range) scale. Abbreviations: CI, Confidence Interval; Logistic, Logistic Regression; Cox, Cox Proportional Hazards Model; AFT,
Accelerated Failure Time Model; MEHP, Mono-(2-ethyl)-hexyl phthalate; MEHHP, Mono-(2-ethyl-5-hydroxyhexyl) phthalate; MEOHP, Mono-(2-ethyl-5-oxohexyl)
phthalate; MECPP, Mono-(2-ethyl-5-carboxypentyl) phthalate; Σ DEHP, Summed DEHP metabolites; MBzP, Mono-benzyl phthalate; MBP, Mono-n-butyl phthalate;
MiBP, Mono-isobutyl phthalate; MEP, Mono-ethyl phthalate; MCPP, Mono-(3-carboxypropyl) phthalate




OR 95% CI HR 95% CI % Change 95% CI
MEHP 1.50 (1.10, 2.07) 1.07 (0.98, 1.17) −0.79% (−1.67, 0.09%)
MEHHP 1.05 (0.75, 1.47) 1.04 (0.94, 1.15) −0.51% (−1.01, 0.32%)
MEOHP 1.23 (0.87, 1.75) 1.09 (0.98, 1.21) −0.76% (−1.74, 0.23%)
MECPP 1.66 (1.20, 2.30) 1.21 (1.09, 1.33) −1.19% (−2.11, −0.26%)
Σ DEHP 1.47 (1.06, 2.03) 1.14 (1.04, 1.26) −1.03% (−1.95, −0.01%)
MBzP 1.27 (0.79, 1.65) 1.15 (1.03, 1.27) −0.60% (−1.63, 0.43%)
MBP 1.35 (0.99, 1.87) 1.17 (1.05, 1.29) −0.74% (−1.75, 0.28%)
MiBP 0.98 (0.66, 1.45) 1.00 (0.90, 1.12) 0.30% (−0.82, 1.44%)
MEP 1.22 (0.87, 1.71) 1.01 (0.91, 1.12) −0.11% (−1.06, 0.86%)
MCPP 1.27 (0.93, 1.72) 1.10 (1.01, 1.20) −0.28% (−1.18, 0.62%)
Phthalates were averaged across the first three visits and log-transformed. All models were adjusted for average specific gravity, maternal age at first visit, race,
and education. The single-pollutant models for MBzP, MBP, MiBP, MEP, and MCPP are also adjusted for health insurance provider. Bolded cells indicate significant
(p < 0.05) odds ratios (OR), hazard ratios (HR), and percent changes (% Change). Odds ratios, hazard ratios and percent changes are all calculated on IQR
(Interquartile Range) scale. Abbreviations: CI, Confidence Interval; Logistic, Logistic Regression; Cox, Cox Proportional Hazards Model; AFT, Accelerated Failure Time
Model; MEHP, Mono-(2-ethyl)-hexyl phthalate; MEHHP, Mono-(2-ethyl-5-hydroxyhexyl) phthalate; MEOHP, Mono-(2-ethyl-5-oxohexyl) phthalate; MECPP, Mono-(2-
ethyl-5-carboxypentyl) phthalate; Σ DEHP, Summed DEHP metabolites; MBzP, Mono-benzyl phthalate; MBP, Mono-n-butyl phthalate; MiBP, Mono-isobutyl
phthalate; MEP, Mono-ethyl phthalate; MCPP, Mono-(3-carboxypropyl) phthalate. *Results are similar to Ferguson and colleagues (2014) [14]
Boss et al. Environmental Health  (2018) 17:56 Page 6 of 13
Descriptive analyses for the phthalate risk scores showed
that ERS-Corr and ERS-Stepwise (Additional file 1: Figure
S2) are approximately normally distributed, whereas
WQS-Corr and WQS-Stepwise are decidedly non-normal.
Additional file 1: Figure S3 contains a Pearson correlation
matrix between the four risk scores. There are mod-
erately strong, pairwise correlations (average correl-
ation around r = 0.6) between ERS-Corr, WQS-Corr,
and WQS-Stepwise, but ERS-Stepwise is weakly corre-
lated with WQS-Corr and WQS-Stepwise. Across
average exposure and repeated measures models,
MEOHP and MECPP had the largest contribution to
the construction of ERS-Stepwise and WQS-Stepwise,
MECPP, MBP, and MiBP had the largest contribution
to the construction of ERS-Corr, and MECPP, MBzP,
and MEP had the largest contribution to the construction
of WQS-Corr (see Additional file 1: Table S5 for a list of
exact weights used in ERS and WQS construction).
Table 3 summarizes the odds ratios, hazard ratios, and
percent change in the ERS and WQS average exposure
analysis models, where ERS and WQS were determined
using mean log-transformed phthalate concentrations. All
models were adjusted for specific gravity, race, education,
maternal age, and health insurance status. One IQR
change in ERS-Corr (OR: 1.81, 95% CI: 1.32, 2.52),
ERS-Stepwise (OR: 2.14, 95% CI: 1.62, 2.87), WQS-Corr
(OR: 1.66, 95% CI: 1.06, 2.64), and WQS-Stepwise (OR:
1.64, 95% CI: 1.01, 2.72) were all associated with a higher
odds of preterm birth. For the Cox proportional hazards
model, ERS-Stepwise (HR: 1.30, 95% CI: 1.16, 1.46) and
WQS-Corr (HR: 1.21, 95% CI: 1.06, 1.38) showed a signifi-
cantly higher risk for shortened gestational length per IQR
change, while ERS-Corr (HR: 1.06, 95% CI: 0.98, 1.14) and
WQS-Stepwise (HR: 1.06, 95% CI: 0.92, 1.23) did not show
a significantly higher risk for shortened gestational length
per IQR change. In the accelerated failure time model,
ERS-Corr (% Change: -1.86, 95% CI: -2.98, − 0.73%),
ERS-Stepwise (% Change: -1.84, 95% CI: -2.78, − 0.88%),
and WQS-Corr (% Change: -1.12, 95% CI: -2.25, − 0.08%)
showed a significant percent decrease in gestational
length per IQR change in the respective risk score.
See Additional file 1: Table S4 for the IQR ranges of
each multi-pollutant risk score.
Figure 1 depicts the odds ratios, hazard ratios, and per-
cent change in gestational age for ERS and WQS quartiles
(see Additional file 1: Table S6 for numerical summaries).
For WQS-Corr, ERS-Corr, and ERS-Stepwise, there is gen-
erally an increasing trend in the odds ratios and hazard
ratios and a decreasing trend in the % change as the re-
spective risk score quartile increases. Namely, WQS-Corr
shows significantly higher odds of preterm birth (OR:
3.33, 95% CI: 1.44, 7.69), significantly higher risk for
shortened gestational length (HR: 1.48, 95% CI: 1.16,
1.89), and a significant percent decrease in gestational
length (% Change: -2.89, 95% CI: -5.01, − 0.71%) for quar-
tile 4 compared to quartile 1.
Two single-pollutant mean exposure models for
MECPP and MBP are also included in Fig. 1 for com-
parison. Notably, the odds ratios, hazard ratios, and %
change corresponding to the single-pollutant models
are attenuated relative to the ERS-Corr, ERS-Stepwise,
and WQS-Corr models. Specifically, if we compare
quartile 4 to quartile 1, then we see that ERS-Corr
has an odds ratio of 3.77 (95% CI: 1.96, 7.25), a
hazard ratio of 1.44 (95% CI: 1.19, 1.75), and a %
change of − 2.55% (95% CI: -4.30, − 0.76%), while the
single-pollutant mean exposure models for MBP have an
odds ratio of 2.25 (95% CI: 1.16, 4.36), a hazard ratio of
1.30 (95% CI: 1.00, 1.69), and % change of − 1.63% (95% CI:
-4.03, 0.82%). Thus, measures of aggregate phthalate
exposure, notably ERS-Corr, ERS-Stepwise, and
WQS-Stepwise, quantify a stronger association between
phthalate exposure and gestational length, compared to
single-pollutant models.
Table 3 Association of gestational age with summative phthalate risk scores
Logistic Cox AFT
Risk Score OR 95% CI HR 95% CI % Change 95% CI
Average Exposure Analysis
ERS-Corr 1.81 (1.32, 2.52) 1.06 (0.98, 1.14) −1.86% (−2.98, − 0.73%)
ERS-Stepwise 2.14 (1.62, 2.87) 1.30 (1.16, 1.46) −1.84% (−2.78, − 0.88%)
WQS-Corr 1.66 (1.06, 2.64) 1.21 (1.06, 1.38) −1.12% (−2.25, −0.08%)
WQS-Stepwise 1.64 (1.01, 2.72) 1.06 (0.92, 1.23) −0.57% (−1.83, 0.70%)
Repeated Measures Analysis
ERS-Corr 1.89 (1.45, 2.51) 1.19 (1.10, 1.27) −1.33% (−2.03, −0.63%)
ERS-Stepwise 1.77 (1.37, 2.31) 1.23 (1.14, 1.34) −0.85% (−1.60, − 0.10%)
Phthalate measurements at each visit were log-transformed. All average exposure models were adjusted for average specific gravity, maternal age at first visit,
race, education, and health insurance provider. All repeated measures models were adjusted for specific gravity at each visit, time of sample collection, maternal
age at first visit, race, education, and health insurance provider. Bolded cells indicate significant (p < 0.05) odds ratios (OR), hazard ratios (HR), and percent
changes (% Change). Odds ratios, hazard ratios and percent changes are all calculated on IQR (Interquartile Range) scale. Abbreviations: CI, Confidence Interval;
Logistic, Logistic Regression; Cox, Cox Proportional Hazards Model; AFT, Accelerated Failure Time Model
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Table 3 also summarizes the odds ratios, hazard ratios,
and percent change in the ERS exposure analysis
models, where ERS is determined using repeated mea-
sures of phthalate concentrations. For ERS-Corr (OR:
1.89, 95% CI: 1.45, 2.51; HR: 1.19, 95% CI: 1.10, 1.27; %
Change: -1.33, 95% CI: -2.03, − 0.63%) and ERS-Stepwise
(OR: 1.77, 95% CI: 1.37, 2.31; HR: 1.23, 95% CI: 1.14,
1.34; % Change: -0.85, 95% CI: -1.60, − 0.10%) we ob-
serve an elevated odds, higher risk of lower gestational
length, and a percent decrease in gestational length per
IQR change in their respective ERS (see Random Inter-
cept column in Additional file 1: Table S4 for repeated
measures ERS IQR ranges).
Discussion
In this paper, we make two primary contributions. The
first is to analyze gestational age at delivery in a time to
event framework. Modeling time to delivery as a con-
tinuous variable addresses the limitations of using
dichotomous outcomes such as term versus preterm
birth, which may oversimplify the pathological conse-
quences of shorter gestational periods. The second is to
use phthalate risk scores, such as ERS and WQS, as
summary measures to estimate the cumulative effect of
phthalate mixtures. We examined four different risk
scores, and found that three of the four, ERS-Corr,
ERS-Stepwise, and WQS-Corr, were significantly associ-
ated with time to delivery. Simulation studies need to be
conducted to better understand the analytical benefits
and drawbacks of using ERS compared to WQS.
Overall, this study provides further evidence that select
phthalates are associated with risk factors for adverse re-
productive and birth outcomes. Namely, several individ-
ual phthalates, such as MECPP and summed DEHP
metabolites, were associated with an increased odds of
preterm delivery, an increased risk of delivering, and a
reduced gestational duration. Associations from the re-
peated measures analysis for individual pollutants appear
Fig. 1 Forest plot of associations between gestational age and risk score quartiles (reference category is quartile 1). ERS/WQS was generated from
the average exposure analysis and categorized into quartiles. Single-pollutant average exposure models for MECPP and MBP, where MECPP and
MBP are split into quartiles, are also included. Models were adjusted for average specific gravity, maternal age at first visit, race, education, and
health insurance provider. Exact numerical results can be found in Additional file 1: Table S6
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to be attenuated compared to the associations from the
average exposure analysis. This is primarily due to the
limited number of repeated measures for each subject
and the additional variability that is introduced as a
result of computing the BLUP estimates in the
first-stage model. When comparing the models with
multi-pollutant risk scores to single pollutant models,
we found that ERS-Corr and WQS-Corr were associated
with an even greater reduction in gestational duration
and higher odds of preterm birth in comparison to indi-
vidual phthalate metabolites. These findings align with
the hypothesis that mixtures of multiple pollutants may
have greater adverse effects in comparison to
single-pollutants evaluated in isolation.
Analytically, logistic regression, Cox proportional haz-
ards model, and accelerated failure time model (AFT)
estimate different quantities, and thus the significance
and interpretation of single phthalate metabolites and
summative phthalate risk scores are likely to vary across
the three models. Logistic regression estimates odds ra-
tios, intrinsically related to a dichotomized outcome and
most commonly used measure in this context. The haz-
ard ratio estimate obtained from the Cox proportional
hazards model can be understood as a ratio of the
hazard rates for women with high and low phthalate ex-
posure, respectively. A hazard ratio greater than one in-
dicates that a woman with greater phthalate exposure
has a higher probability of instantaneously giving birth
compared to a woman with lower phthalate exposure,
given that both women have not delivered up to that
time point. Although the Cox proportional hazards
model is very popular for time to event data, the inter-
pretation in the context of gestational duration is some-
what unusual as everybody experiences the event and
the time to delivery data is left skewed instead of being
right skewed (typically noted for survival outcomes).
The AFT model has a much simpler interpretation;
namely, a negative coefficient implies that, on average,
women with higher phthalate exposure would expect a
reduction is gestational duration compared to women
with lower phthalate exposure. Given the ease of inter-
pretation on the direct gestational age scale, we believe
that AFT is better suited for studies of time to gestation.
Preterm delivery, defined as gestational duration less
than 37 weeks, can be an informative and clinically rele-
vant outcome to predict maternal and child health out-
comes. However, there are also other dichotomous cutoffs,
such as late preterm (34–36 weeks gestation), moderate
preterm (32–33 weeks gestation), very preterm (< 32 weeks
gestation) and extremely premature birth (< 28 weeks ges-
tation) [30, 31]. Even among term pregnancies that result
in delivery after 37 weeks gestation, there is considerable
variation in days of gestation prior to delivery [32]. Further-
more, post-term births that take place after 42 weeks
gestation also contribute to perinatal morbidity [30]. There
may be distinct and overlapping pathological consequences
associated with each of these gestational age ranges, there-
fore, analyzing continuous gestational age as an outcome
variable may characterize a more accurate understanding
of the relationship between maternal phthalate levels and
overall duration of pregnancy. Our study reported a reduc-
tion in gestational duration that ranged between 0 and 3%
for most predictor variables, which we recognize may not
be clinically significant on the individual level. However,
given the ubiquity of phthalate exposure, we emphasize
that the reduction in gestational duration associated with
phthalate exposure, averaged among all births that take
place in the U.S. population, could have widespread soci-
etal level effects.
Several investigators have previously characterized as-
sociations between concentrations of phthalate metabo-
lites during pregnancy and either gestational age or
preterm birth, however, their methodological approach
differed from our present study – previous studies have
mostly estimated associations with gestational age
through linear regression [12, 13, 31, 33–39]. Although
these previous studies do not address phthalate mix-
tures, some of these studies have found parallel findings
to our single-pollutant analyses. Weinberger and col-
leagues (2013) assessed the relationship between phthal-
ate metabolites and gestational age in 72 women from
New Jersey, and reported that maternal urinary MEHHP
was associated with a decrease in gestational age [31]. In
another study of 68 women from Michigan, Watkins
and colleagues (2016) observed an inverse relationship
between the sum of DBP metabolites (MBP, MHBP,
MCPP) at delivery and gestational age [38]. Polanska
and colleagues (2016) observed significant inverse asso-
ciations between maternal MEP in the third trimester
and gestational age from a prospective birth cohort in
Poland (N = 165) [36]. In a cohort of strictly African
American and Dominican women in New York (N = 331),
Whyatt and colleagues (2009) found that shorter gesta-
tional duration was significantly associated with higher
maternal urinary concentrations of MEHP, MEHHP,
MEOHP, and MECPP in the third trimester [13]. In
addition to these studies, a small case-control study of
women from Mexico (N = 60) reported that maternal
urinary MECPP, MBP, and MCPP during the third trimes-
ter was significantly associated with an increase in the
odds of preterm birth [12].
Aside from maternal urinary levels of phthalate metab-
olites, one of the studies focused on metabolite concen-
trations in cord blood [34]. In this study of 207 women
from China, associations between cord blood levels of
phthalates and gestational age were estimated [34]. Con-
centrations of several phthalates in cord blood (DMP,
DEP, DEEP, DPP, BMPP, DNHP, BBP, DNOP, DMEP,
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DBP, DIBP, DBEP, and DNP) were significantly associ-
ated with shorter gestational age [34]. Another study in
Italy (N = 84) found lower gestational age among infants
with detectable cord blood concentrations of MEHP in
comparison to infants without detectable MEHP [35].
Among the existing studies reviewed here, some have
also found contrary or null results in comparison to our
study. Adibi and colleagues (2009) drew from a multi-
center U.S. pregnancy cohort (N = 283), and found ma-
ternal urinary concentrations of the metabolites MEHP,
MEOPP, and MEHPP to be significantly associated with
lower odds of preterm birth [33]. Meanwhile, these in-
vestigators also reported significant increase in odds for
delivery past 41 weeks gestation in relation to higher
urinary concentrations of MEHP, MEOHP, and MEHPP
[33]. Similar to these findings, a study of 404 women in
New York also reported a positive association between
maternal MEHP concentrations in the third trimester in
relation to longer gestational age [39]. Another study of
pregnant women in Japan (N = 149) by Suzuki and col-
leagues (2010) resulted in non-significant associations
between 9 different phthalate metabolites (MMP, MEP,
MnBP, MBzP, MEHP, MEHHP, and MEOHP) and ges-
tational age [37]. Contrasting findings from previous
studies may be due to differences in exposure assess-
ment – most of these studies measured phthalates
using single spot urine samples. Another reason could
be due to geographical dissimilarities in the location
of study participants, given that phthalate exposure
may vary by country and region.
Phthalates are metabolized quickly in the body, and as
a mixture, they may be interacting with several target
tissues to elicit changes in various endogenous signaling
molecules, such as hormones, and markers of inflamma-
tion and oxidative stress [20, 40]. There are several po-
tential mechanisms by which phthalate mixtures can
disrupt the production and circulation of endogenous
biomarkers, due to their ability to interact with nuclear
receptors and transcription factors, such as estrogen and
progesterone receptors, aryl hydrocarbon receptors, per-
oxisome proliferator-activated receptors, and thyroid re-
ceptors [40–42]. Human and animal studies indicate
that select phthalate metabolites have been associated
with disruption of several circulating hormones, inflam-
mation and oxidative stress markers [42–45]. With con-
cern for reproductive health, phthalate exposure may
alter gestational duration by acting through these mech-
anistic pathways. Through shortened gestational dur-
ation, phthalate exposure may contribute to adverse
neonatal outcomes and child morbidity later in life.
Though we present a comprehensive analytical frame-
work to capture time and multiple pollutants in an
omnibus analysis, there are several methodological limi-
tations. First, the accelerated failure time model in our
analysis, which is typically used for right-skewed out-
comes, is modeling a left-skewed outcome, namely ges-
tational duration. Therefore, as a sensitivity check, we fit
accelerated failure time models on a transformed version
of gestational age, such that the log of the transformed
gestational age was normally distributed (results not pre-
sented). In terms of significance and direction, trans-
formed and untransformed time to delivery produced
consistent findings. Regression parameters for the
models with untransformed time to delivery are more
straightforward to interpret, however, in modeling a
log-transformed left-skewed outcome, estimates of the
percent reduction in gestational age may be heavily in-
fluenced by a small number of subjects with very short
gestational duration. Second, ERS is calculated and used
on the same data and thus has the potential for overfit-
ting. Before using the phthalate ERS as a prognostic tool,
one needs to validate it in an independent cohort. Third,
we did not collect data on dietary patterns prior to or
during pregnancy, which may confound the relationship
between phthalates and gestational duration.
One major challenge in multipollutant modeling is the
selection of etiologically relevant contaminant mixtures
in the presence of potentially highly collinear exposures.
WQS is specifically designed to handle moderately cor-
related predictors, however variable selection properties
of WQS under a high degree of multicollinearity are not
well-studied. Czarnota and colleagues (2015) argued that
variable selection in the presence of moderate multicolli-
nearity using an ad hoc threshold for WQS weights out-
performs regularized regression methods such as elastic
net, but there is no theoretical justification for their
claim or the choice of the threshold [46]. Moreover,
Czarnota and colleagues (2015) note that they expect
WQS to have worse performance when subject to highly
correlated contaminants [46]. Given that logistic regres-
sion is known to have poor performance under strong
multicollinearity, we would also expect our ERS con-
struction method to have difficulty with highly collinear
phthalate metabolites [47]. In such situations, ridge
regression type methods may have more desirable prop-
erties for constructing risk scores though they do not
lead to unbiased estimates of each of the separate
coefficients.
In our multipollutant models, ERS is based on a model
with linear phthalate main effects and does not capture
potential interactions or non-linearity in the response
surface. However, there are multiple strategies for con-
structing exposure risk scores that do simultaneously ac-
count for nonlinearity and high order interactions in the
response surface [48]. Bayesian Additive Regression
Trees (BART) sum individual regression trees together
to estimate a flexible multivariable function of exposures
that is associated with the health outcome of interest
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[49]. Similar to BART, Bayesian Kernel Machine Regres-
sion (BKMR) also aims to estimate a multivariable func-
tion of exposures that is associated with the health
outcome of interest, but instead uses kernels to approxi-
mate a wide array of possible functional forms [50]. Both
methods should be considered when it is contextually
important to incorporate interactions between exposures
into the ERS generative model.
Additionally, we want to point out that ERS and WQS
are both typically calculated using the same structure of
the analysis model. Ideally, the ERS should be constructed
based on fitting Cox regression on training data and valid-
ating on the test data. However, in our present analysis,
ERS and WQS are each generated from a logistic regres-
sion model and are subsequently used as explanatory vari-
ables in Cox proportional hazards models and AFT
models. The main issue with using continuous gestational
age in ERS/WQS construction is that ERS/WQS needs to
be generated separately for Cox regression and AFT, be-
cause model parameters for Cox regression and AFT cor-
respond to different interpretable quantities (hazard ratio
and percent reduction in gestational age, respectively) and
are on different scales. Another reason for using ERS from
models with preterm birth as an outcome is that most of
the published data are available on this outcome rather
than considering gestational age as a time to event out-
come. Thus if other investigators wanted to construct ERS
based on coefficients reported in other published studies,
the ERS we proposed would be comparable.
Lastly, our study is also limited by the reality that
phthalates are highly variable, and measurements reflect
recent exposures [20]. We previously reported interclass
correlation coefficients (ICC) of phthalates from this
study population [19], which represents the ratio of
intra-individual variability to the sum of intra and
inter-individual variability and range from zero to one,
where values equal to one indicate no intra-individual
variability [51]. ICC for phthalates in this study popula-
tion ranged from 0.19 to 0.61, indicating low to moder-
ate intra-individual variability. As such, our exposure
assessment of phthalates may suffer from some degree
of non-differential measurement error.
Despite these limitations, our study has several
strengths. First, we obtained up to four urine samples
from a large cohort of pregnant women. Compared to
single spot urine measurements, having multiple re-
peated measurements affords a robust exposure assess-
ment, and reduces non-differential measurement error
due to intra-individual phthalate variability. Our study
also used highly sensitive analytical methods to measure
urinary phthalate metabolites, which resulted in high de-
tection rates. Finally, our study was strengthened by our
assessment of gestational dates, which were validated
both clinically and with first-trimester ultrasonography.
Finally, we would like to emphasize that for non-detects





lead to optimal statistical properties. This is less of a con-
cern in our analysis as a very small proportion of phthalate
metabolite concentrations are below their respective
LODs (Table S3). For studies with higher proportions of
non-detects one may want to use more rigorous ap-
proaches for handling non-detects, such as multiple im-





substitution could heavily bias
regression parameter estimates for constructing ERSs,
even if the proportion of non-detects is relatively small,
i.e., around 15–20% [54–56].
Conclusions
Environmental exposure to phthalates remain a persistent
public health concern, especially within the context of preg-
nancy. The present study determined that several phtha-
lates and phthalate risk scores, which quantify the isolated
effect of a single phthalates and the aggregate effect of mul-
tiple phthalates, respectively, were associated with short-
ened gestational duration in the Cox proportional hazards
models, the accelerated failure time models, and logistic re-
gression models. Furthermore, this study provides a novel
statistical framework for investigators to analyze the simul-
taneous effect of multiple pollutants. Future studies should
aim to characterize potential biological mediators that
relate phthalate exposure and gestational duration.
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